During tumour formation and expansion, cancer cells encounter constantly changing environmental conditions in which nutrient and oxygen availability may be severely compromised. The metabolic transformation of cancer cells is characterised by distinct changes in metabolic activity that satisfy the exigencies of energy and biomass production imposed by continued cell proliferation. These metabolic adaptations often involve increased consumption and metabolism of extracellular nutrients, mainly glucose, amino acids and lipids. During periods of nutrient or oxygen deprivation, cancer cells can also modify their metabolism to adapt to these specific challenges. Here we report the results of a functional genomics study that revealed that the activity of acetyl-coA synthetase 2, an enzyme that converts acetate into acetyl-coA, contributes to cellular growth under oxygen and nutrient stressed conditions. ACSS2 was required to provide acetyl groups for lipid biosynthesis. Moreover, ACSS2 was essential for cancer cell growth and survival under physiologically relevant growth conditions and its depletion blocked tumour growth in vivo. In summary, our data demonstrate a previously unappreciated role for acetate as a nutritional source for the growth and survival of breast and prostate cancer cells under metabolic stress.
. 2014 May 28;2(Suppl 1):O9. doi: 10.1186/2049-3002-2-S1-O9
Acetyl-coA synthetase 2 promotes acetate utilization and maintains cell growth under metabolic stress
Zachary Schug
1,✉, Barrie Peck
2, Dylan Jones
3, Qifeng Zhang
4, Israt Alam
5, Tim Witney
5, Elizabeth Smethurst
4, Shaun Grosskurth
6, Adrian Harris
3, Susan Critchlow
6, Eric Aboagye
5, Michael Wakelam
4, Almut Schulze
2,7, Eyal Gottlieb
1
Adrian Harris
3Weatherall Institute for Molecular Medicine, Oxford, UK
Find articles by Adrian Harris
Almut Schulze
2CR-UK London Research Institute, London, UK
7Theodor Boveri Institute, Wurzburg, Germany
Find articles by Almut Schulze
1CR-UK The Beatson Institute, Glasgow, UK
2CR-UK London Research Institute, London, UK
3Weatherall Institute for Molecular Medicine, Oxford, UK
4The Babraham Institute, Cambridge, UK
5Imperial College, London, UK
6AstraZeneca, Macclesfield, UK
7Theodor Boveri Institute, Wurzburg, Germany
✉
Corresponding author.
Supplement
Metabolism, Diet and Disease 2014: Cancer and metabolism
This supplement has not been supported by sponsorship.
Conference
28-30 May 2014
Metabolism, Diet and Disease 2014: Cancer and metabolism
Washington DC, USA
Collection date 2014.
Copyright © 2014 Schug et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
PMCID: PMC4072991
